Skip to main content

Enovis’ ARVIS® Awarded the AAHKS Industry Innovation Award at the 2022 American Academy of Hip and Knee Surgeons Annual Meeting

AAHKS Innovation Award Presentation

Nick van der Walt, Selene van der Walt, Chad Rains, Jonathan Nielsen and Louie Vogt accepted the AAHKS Industry Innovation Award. They are joined by Dr. Lucian Warth and Dr. Bryan D. Springer, President of AAHKS.
Nick van der Walt, Selene van der Walt, Chad Rains, Jonathan Nielsen and Louie Vogt accepted the AAHKS Industry Innovation Award. They are joined by Dr. Lucian Warth and Dr. Bryan D. Springer, President of AAHKS.

Wilmington, DE, Nov. 10, 2022 (GLOBE NEWSWIRE) — Today, Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced that the company’s ARVIS® Augmented Reality Surgical Guidance System received the Industry Innovation Award at the this year’s American Academy of Hip and Knee Surgeons (AAHKS) Annual Meeting. This annual award recognizes cutting-edge innovation in products, procedures and services in the field of Hip and Knee Arthroplasty.

ARVIS is the only FDA-cleared proprietary, real-time, hands-free augmented reality (AR) technology engineered for orthopedic surgeons, so they can visualize precision guidance when performing hip and knee surgery. With its streamlined design, ARVIS has a more economical price and footprint than large robotic systems, so it can be easily adopted and scaled by a wide array of ambulatory surgical centers and hospitals, allowing more access to patients wishing to experience the benefits of a technology assisted knee or hip replacement.

“We are absolutely thrilled to receive this award and be recognized by such a prestigious organization as AAHKS,” said Louie Vogt, President and General Manager, Enovis Surgical™. “ARVIS represents the next era of orthopedic technology and we look forward to continuing to expand our feature set and capabilities to improve patient care and outcomes with cutting-edge innovation in the future.”

ARVIS is compatible with Enovis’ innovative EMPOWR Hip and Knee product offerings, including EMPOWR™ 3D, Porous and Partial Knee, EMPOWR Acetabular® and Dual Mobility, along with compatible femoral stems.

For more information, visit enovis.com/arvis.

About Enovis
Enovis Corporation (NYSE: ENOV) is an innovation-driven, medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services, and integrated technologies fuels active lifestyles in orthopedics and beyond. For more information about Enovis, please visit www.enovis.com.

Media Contact:

Cristina Pasquino
Communications Manager
Enovis Corporation
+1-772-382-9121
Cristina.Pasquino@enovis.com 

Source: Enovis Corporation

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.